Coeptis Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $862 | $237 | $200 | $62 |
Gross Profit | -3,198 | 192 | 155 | 17 |
EBITDA | -2,285 | -2,530 | -3,961 | -3,044 |
EBIT | -2,591 | -2,836 | -4,266 | -3,349 |
Net Income | -1,577 | -159 | -3,534 | -3,057 |
Net Change In Cash | 862 | 237 | 200 | 62 |
Free Cash Flow | -1,687 | -2,152 | -2,396 | -2,366 |
Cash | 5,674 | 4,908 | 1,996 | 4,268 |
Basic Shares | 4,234 | 4,745 | 3,706 | 3,073 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,363 | $0 | $0 | $0 |
Gross Profit | -2,832 | -1,038 | -1,001 | -1,001 |
EBITDA | -11,820 | -9,442 | -20,157 | -36,354 |
EBIT | -13,043 | -10,481 | -21,158 | -37,355 |
Net Income | -11,917 | -10,877 | -21,266 | -37,574 |
Net Change In Cash | 1,363 | 0 | 0 | 0 |
Free Cash Flow | -8,603 | -6,649 | -3,875 | -3,875 |
Cash | 5,674 | 532 | 3,791 | 3,791 |
Basic Shares | 4,234 | 1,925 | 25,690 | 14,296 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.58 |
2025-06-30 | -$0.95 |
2025-03-31 | -$0.95 |
2024-12-31 | -$1.42 |